Jenkem Technology Co Ltd
SSE:688356
Jenkem Technology Co Ltd
Operating Income
Jenkem Technology Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jenkem Technology Co Ltd
SSE:688356
|
Operating Income
¥193.7m
|
CAGR 3-Years
46%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Operating Income
¥7.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥4.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
See Also
What is Jenkem Technology Co Ltd's Operating Income?
Operating Income
193.7m
CNY
Based on the financial report for Dec 31, 2022, Jenkem Technology Co Ltd's Operating Income amounts to 193.7m CNY.
What is Jenkem Technology Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
49%
Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for Jenkem Technology Co Ltd have been 46% over the past three years , 49% over the past five years .